西班牙多中心注册研究中2019 ACR/EULAR IgG4相关疾病分类标准的性能与临床表型
该研究基于西班牙REERIGG4多中心注册的105例IgG4相关疾病患者,评估了2019 ACR/EULAR分类标准的性能和表型分布。西班牙患者中腹膜后和主动脉表型较亚洲系列更常见,而Mikulicz和系统性表型较少。
要点
- 未符合标准的主要原因是评分不足20分(67%)和满足排除标准(33%)。
- 病理报告不完整是未能符合分类标准的首要原因。
核心结论
- 西班牙IgG4-RD患者中约四分之三符合2019 ACR/EULAR分类标准,病理报告不完整是未符合标准的主要原因。
主要发现
- 诊断时86%符合国际病理共识,92%符合日本综合标准。
- 病理报告不完整与未能符合分类标准相关。
关键数值与推荐
- 2019 ACR/EULAR分类标准要求评分≥20分且不满足排除标准。
临床怎么用
- 在西班牙IgG4-RD患者中应用2019 ACR/EULAR分类标准时需注意病理报告的完整性,并考虑未定义表型的存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Several IgG4-related disease (IgG4-RD) phenotypes have been proposed and the first set of classification criteria have been recently created. Our objectives were to assess the phenotype distribution and the performance of the classification criteria in Spanish patients as genetic and geographical differences may exist. METHODS: We performed a cross-sectional multicentre study (Registro Español de Enfermedad Relacionada con la IgG4, REERIGG4) with nine participating centres from Spain. Patients were recruited from November 2013 to December 2018. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria (AECC) were used. RESULTS: We included 105 patients; 88% had Caucasian ethnicity. On diagnosis, 86% met the international pathology consensus while 92% met the Japanese comprehensive criteria. The phenotype distribution was head and neck 25%, Mikulicz and systemic (MS) 20%, pancreato-hepato-biliary (PHB) 13%, retroperitoneal and aorta (RA) 26%. Sixteen per cent had an undefined phenotype. Seventy-seven per cent of the cases met the AECC. From the 24 patients not meeting the AECC, 33% met exclusion criteria, and 67% did not get a score ≥20 points. Incomplete pathology reports were associated to failure to meet the AECC. CONCLUSIONS: The PHB phenotype was rare among Spanish IgG4-RD patients. The MS phenotype was less frequent and the RA phenotype was more prevalent than in other, Asian patient series. An undefined phenotype should be considered as some patients do not fall into any of the categories. Three quarters of the cases met the 2019 AECC. Incomplete pathology reports were the leading causes of failure to meet the criteria.
引用
- Fernández-Codina A, Pinilla B, Pinal-Fernández I, et al. Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4). Rheumatology (Oxford). 2021. PMID: 32658963. doi:10.1093/rheumatology/keaa247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。